Bülent Elibol

3.2k total citations
58 papers, 1.8k citations indexed

About

Bülent Elibol is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Bülent Elibol has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Neurology, 11 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Bülent Elibol's work include Parkinson's Disease Mechanisms and Treatments (33 papers), Neurological disorders and treatments (17 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). Bülent Elibol is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (33 papers), Neurological disorders and treatments (17 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). Bülent Elibol collaborates with scholars based in Türkiye, United States and Italy. Bülent Elibol's co-authors include Mario Vallejo, Ann M. Graybiel, Rosario Moratalla, Esen Saka, Turgay Dalkara, Alberto Albanese, Antonio Emanuele Elia, Graziella Filippini, Nardo Nardocci and Friedrich Asmus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Bülent Elibol

54 papers receiving 1.7k citations

Peers

Bülent Elibol

NEURO

CMN

NEURO

PHYSI

Bi Zhao China

Johann Hagenah Germany

Wei Song China

Penelope Hogarth United States

Yasuhiko Baba Japan

Gholam Ali Shahidi Iran

Naheed L. Khan United Kingdom

Ruwei Ou China

Dietrich Haubenberger United States

V. Scaioli Italy

Bi Zhao China

Bülent Elibol

1.5k ×1.5

NEURO

442 ×0.6

CMN

410 ×0.8

383 ×1.2

NEURO

274 ×1.3

PHYSI

Citations per year, relative to Bülent Elibol Bülent Elibol (= 1×) peers Bi Zhao

Countries citing papers authored by Bülent Elibol

Since Specialization

Citations

This map shows the geographic impact of Bülent Elibol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bülent Elibol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bülent Elibol more than expected).

Fields of papers citing papers by Bülent Elibol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bülent Elibol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bülent Elibol. The network helps show where Bülent Elibol may publish in the future.

Co-authorship network of co-authors of Bülent Elibol

This figure shows the co-authorship network connecting the top 25 collaborators of Bülent Elibol. A scholar is included among the top collaborators of Bülent Elibol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bülent Elibol. Bülent Elibol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Çakmaklı, Gül Yalçın, Eser Lay Ergün, Kader Karlı Oğuz, et al.. (2025). Multimodal imaging analysis of autosomal recessive Parkinson’s disease. Annals of Nuclear Medicine. 39(8). 813–822. 1 indexed citations

Çakmaklı, Gül Yalçın, et al.. (2025). The impact of perioperative aspirin utilization on postoperative hemorrhagic complications in idiopathic normal pressure hydrocephalus: a single-center retrospective analysis. Neurosurgical Review. 48(1). 304–304.

Önder, Halil, Kader Karlı Oğuz, Arzu Ceylan Has, & Bülent Elibol. (2023). Comparative analysis of freezing of gait in distinct Parkinsonism types by diffusion tensor imaging method and cognitive profiles. Journal of Neural Transmission. 130(4). 521–535. 1 indexed citations

Fasano, Alfonso, Victor S.C. Fung, Klaus Seppi, et al.. (2022). Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study. Acta Neurologica Scandinavica. 146(2). 167–176. 7 indexed citations

Elibol, Bülent, et al.. (2022). Sleep disorders and polysomnography findings in patients with autoimmune encephalitis. Neurological Sciences. 44(4). 1351–1360. 6 indexed citations

Stelten, Bianca M. L., Maria Teresa Dotti, Aad Verrips, et al.. (2021). Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study. Orphanet Journal of Rare Diseases. 16(1). 353–353. 26 indexed citations

Armutlu, Kadriye, et al.. (2018). Sensorimotor integration training in Parkinson’s disease. Neurosciences. 23(3). 208–215. 17 indexed citations

Olgiati, Simone, Okan Doğu, Zeynep Tüfekçıoğlu, et al.. (2017). The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. Parkinsonism & Related Disorders. 39. 64–70. 31 indexed citations

Erer, Sevda, Ünal Egelí, Mehmet Zarifoğlu, et al.. (2016). Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson’s patients and genotype-phenotype correlations. Clinical Neurology and Neurosurgery. 148. 147–153. 19 indexed citations

10.

Balkan, Ayla Fil, Kadriye Armutlu, Songül Aksoy, Hülya Kayıhan, & Bülent Elibol. (2014). Parkinson Hastalarında Duyu Bütünlüğü Eğitiminin Postüral İnstabiliteye Etkisi. 2(2). 91–104. 1 indexed citations

11.

Çakmaklı, Gül Yalçın, Simone Olgiati, Marialuisa Quadri, et al.. (2014). A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism. Parkinsonism & Related Disorders. 20(11). 1248–1252. 34 indexed citations

12.

Albanese, Alberto, Friedrich Asmus, Kailash P. Bhatia, et al.. (2010). EFNS guidelines on diagnosis and treatment of primary dystonias. European Journal of Neurology. 18(1). 5–18. 293 indexed citations

13.

Gündüz, Ayşegül, et al.. (2009). Comparison of different balance scales in Parkinson's disease. DergiPark (Istanbul University).

14.

Saka, Esen, Mehmet Akif Topçuoğlu, Ahmet Demir, & Bülent Elibol. (2009). Transcranial sonography in Perry syndrome. Parkinsonism & Related Disorders. 16(1). 68–70. 8 indexed citations

15.

Tomiyama, Hiroyuki, Yuanzhe Li, Yoko Imamichi, et al.. (2008). Mutation Analysis of the PINK1 Gene in 391 Patients With Parkinson Disease. Archives of Neurology. 65(6). 802–8. 68 indexed citations

16.

Uysal, Hilmi, Isın Ünal-Çevik, Figen Söylemezoğlu, et al.. (2003). Is the Cell Death in Mesial Temporal Sclerosis Apoptotic?. Epilepsia. 44(6). 778–784. 27 indexed citations

17.

Elibol, Bülent, Figen Söylemezoğlu, Masazumi Fujii, et al.. (2001). Nitric oxide is involved in ischemia-induced apoptosis in brain: a study in neuronal nitric oxide synthase null mice. Neuroscience. 105(1). 79–86. 41 indexed citations

18.

Anlar, Banu, Figen Söylemezoğlu, Bülent Elibol, et al.. (1999). Apoptosis in Brain Biopsies of Subacute Sclerosing Panencephalitis Patients. Neuropediatrics. 30(5). 239–242. 15 indexed citations

19.

Moratalla, Rosario, Mario Vallejo, Bülent Elibol, & Ann M. Graybiel. (1996). D1-class dopamine receptors influence cocaine-induced persistent expression of Fos-related proteins in striatum. Neuroreport. 8(1). 1–5. 99 indexed citations

20.

Moratalla, Rosario, Bülent Elibol, Mario Vallejo, & Ann M. Graybiel. (1996). Network-Level Changes in Expression of Inducible Fos–Jun Proteins in the Striatum during Chronic Cocaine Treatment and Withdrawal. Neuron. 17(1). 147–156. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact